U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H21ClN2O4
Molecular Weight 424.877
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GEDOCARNIL

SMILES

COCC1=C(N=CC2=C1C3=C(N2)C=CC=C3OC4=CC=C(Cl)C=C4)C(=O)OC(C)C

InChI

InChIKey=SLYDYLLJUXFULK-UHFFFAOYSA-N
InChI=1S/C23H21ClN2O4/c1-13(2)29-23(27)22-16(12-28-3)20-18(11-25-22)26-17-5-4-6-19(21(17)20)30-15-9-7-14(24)8-10-15/h4-11,13,26H,12H2,1-3H3

HIDE SMILES / InChI

Description

Anxiolytic drug, Gedocarnil [SH 530, ZK 113315], was undergoing phase I clinical trials with Schering AG in Germany as a potential nootropic agent. However it`s development for the treatment of cognition disorders was discontinued.

Originator

Approval Year

Unknown
149124
Patents

Patents

WO2011089216A1
1
WO2014052394A1
1
Name Type Language
GEDOCARNIL
INN   WHO-DD  
INN  
Official Name English
Gedocarnil [WHO-DD]
Preferred Name English
gedocarnil [INN]
Common Name English
ISOPROPYL 5-(P-CHLOROPHENOXY)-4-(METHOXYMETHYL)-9H-PYRIDO(3,4-.BETA.)INDOLE-3-CARBOXYLATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28197
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
WHO-VATC QN05BX02
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
WHO-ATC N05BX02
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID20148993
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
PUBCHEM
219095
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
EVMPD
SUB07888MIG
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
CAS
109623-97-4
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105080
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
NCI_THESAURUS
C74183
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
INN
6285
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
FDA UNII
BWP53NPW3F
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
DRUG BANK
DB13534
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
WIKIPEDIA
GEDOCARNIL
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
SMS_ID
100000084538
Created by admin on Mon Mar 31 18:07:01 GMT 2025 , Edited by admin on Mon Mar 31 18:07:01 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of GEDOCARNIL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966